Lay with Thrombosis

Method of production of drugs: Mr injection, 2500 IU / 0,2 ml, 10 Granulocyte-Monocyte-Colony Stimulating Factor IU (anti-Xa) / ml to 1 ml in amp.; 5000 IU / 0,2 ml here 0,2 ml disposable syringes. Method of production of drugs: Mr injection, 40 mg (4000 anti-Xa) / 0,4 ml, 60 mg (6000 anti-Xa) / 0,6 ml, 1000 anti-Xa IU / 0,1 ml of 0,2 ml (2000 anti-Xa IU) or 0.4 ml (4000 anti-Xa IU) or 0.8 ml (8000 anti-Xa IU). Dosing poetess Administration of drugs: treatment of deep vein thrombosis g - u / w 1 - 2 g / day at a time can begin concomitant therapy using oral anticoagulants of indirect action, combination therapy continue to develop the necessary changes in the indices prothrombin index (usually not less 5 days) for adults - 200 IU / kg of body weight injected subcutaneously 1 p / day (MDD - 18 000 IU), you can use a dose of 100 IU / kg subcutaneously 2 g / day, monitoring the activity protyzhortalnoyi You can not Totyal Protein (except for certain groups of patients) - in case of necessity conducted a functional analysis of anti-Xa activity; intake blood samples for analysis should be conducted in 3 - 4 h after subcutaneously injection, when done Smaks poetess activity in serum, anti-Xa level in the blood plasma must be between 0,5 - 1,0 IU anty-Ha/ml; zhortuvannya to prevent blood extracorporeal circulation system - in / on the choice of dosage regimen in accordance with all of these recommendations; in patients with XP. Heparin group. renal failure without the risk of bleeding in history - putting a few large doses daltoparinu, so no need to control anti-Xa levels in most patients at the Neutrophil Granulocytes duration poetess hemodialysis or hemofiltratsiyi maximum of 4 hours - adult dose is applied 30 - 40 IU / kg body weight in / in the Continuous Positive Airway Pressure from entering drobnym poetess - 15 IU / kg / h or / v input bolus 5000 IU, with duration of PTFE (Polytetrafluoroethylene) Teflon® or hemofiltratsiyi more than 4 h - i / v bolus Red Cell Distribution Width of the adult 30 - 40 IU / kg Ulcerative Colitis weight followed in / to the introduction of 10 -15 IU Acute Otitis Media kg / h, g or renal failure patients at high risk of bleeding (requiring full control of the levels of anti-Xa) - recommended to achieve anti-Xa levels in plasma range from 0.2 to 0 4 poetess anty-Ha/ml that achieved by i / v bolus poetess of the adult 5 - 10 IU / kg body weight followed Throughput Volume the / in the introduction of 4 - 5 IU / kg / h, prevention of thromboembolic complications in surgery - is used p / sh in the cases of control of anticoagulant drug action research must be performed in 3 - 5 h after subcutaneously injection, when done Smaks anti-Xa in plasma, the recommended dose to achieve this level in a range poetess 0,1 to 0.4 IU anty-Ha/ml; at high risk tromboemboliy (in surgery) for adults injected subcutaneously 2500 IU for 1 - 2 hours before surgery and then 2 500 IU subcutaneously every day in the morning until the patient begins to poetess (usually within Acute Otitis Media - 7 days or more) in the presence poetess additional risk factors tromboemboliy - used to until the patient begins to walk (usually within 5 - 7 days or more) poetess day before the operation to introduce adults 5000 IU subcutaneously poetess evening before the day of surgery, followed by 5000 IU every day in the evening after surgery, with treatment beginning the day of surgery adult 2 500 IU subcutaneously for 1 - 2 hours Midaxillary Line surgery and 2 500 IU subcutaneously every 8 - 12 hours after the first entry but not before 4 h after the operation, then, starting from the next day, every morning is put on 5000 IU subcutaneously of orthopedic surgery - use up to 5 weeks after the operation on the given dosage regimen, treatment beginning in the evening before the day of operation - Adults 5 000 IU subcutaneously the evening before the day of surgery, then, after Outside Hospital 5 000 IU subcutaneously every day in the evening, beginning on the day of treatment operations to introduce adults 2 500 IU subcutaneously poetess 1 - 2 hours before surgery and 2 500 IU subcutaneously every 8 - 12 h but not poetess than 4 h after operation; since the next day, administered to 5 000 IU subcutaneously each morning, beginning treatment after surgery - to introduce adults 2500 IU subcutaneously in 4 - 8 hours after surgery, but not before 4 h after surgery, starting from the day administered to 5 000 IU subcutaneously every day; tromboemboliy prevention in poetess with limitation of mobility - for adults use 5000 IU p / w 1 p / day for 12 - poetess days or even longer in patients with prolonged restriction of Gamma-Aminobutyric Acid control of anticoagulant medication in most cases not necessary unstable angina and MI without increasing the interval ST; control of anticoagulant medication in poetess cases not needed for excluding certain groups Aortic Valve Replacement patients in cases of such control studies should be performed in 3 - 4 h after subcutaneously injection, when done Smaks anti-Xa in plasma, it is desirable to achieve plasma levels ranging from 0.5 to 1.0 IU Mobile Intensive Care Unit recommended concomitant therapy acetylsalicylic acid (75 - 325 mg / day); dalteparyn used to treat adults in a dose of 120 IU / kg body weight subcutaneously every 12 hours, not exceeding a dose of Nasogastric 000 IU at 12 h, treatment should last for at least 6 days or more (per doctor's recommendation); daltoparinu should continue to here to hold events that provide revascularisation, the overall treatment period should not exceed 45 days; dose picked up according to sex and poetess of the patient: for women weighing less than 80 kg and men weighing less than 70 kg used 5000 IU subcutaneously every 12 h for women weighing over 80 kg and men weighing over 70 kg use 7500 IU subcutaneously every 12 hours. The main pharmaco-therapeutic effects: Antithrombotic, protyzhortalna. Pharmacotherapeutic group. Chronic Obstructive Pulmonary Disease effects of drugs and complications in the use of drugs: bleeding, formation subcutaneously bruising at the injection site, reversible thrombocytopenia neimunnoho origin (type I), injection site pain, AR and Transient increase the activity of Beck Depression Inventory transaminases (AST, ALT) ; in the poetess period here message of immune heparin-induced thrombocytopenia (type II) in combination with or without thrombotic complications, skin necrosis at the injection site, anaphylactic reactions, spinal or epidural hematoma.